Swing Therapeutics, Inc.

📍 San Francisco, United States🗓 Founded 2019👥 24 employees💰 Last funded Jan 2022
Biotechnology Research🌐 swingtherapeutics.com
Website LinkedIn
Swing Therapeutics was founded in 2019 with the goal of developing digital treatments in disease areas where patients are not well-served, and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) like fibromyalgia where central pain sensitization is a significant factor. The company is investing in research to support the development and validation of its pipeline of prescription-based digital therapies. Swing Therapeutics’ near-term goal is to validate its digital program for the treatment of fibromyalgia and bring it to market as an FDA-cleared, prescription-based digital therapeutic.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Swing Therapeutics, Inc.?
Swing Therapeutics, Inc. has 2 investors on record on gritt.io, 2 mid-stage.
When did Swing Therapeutics, Inc. last raise funding?
The most recent investment in Swing Therapeutics, Inc. recorded on gritt.io was in January 2022.
When was Swing Therapeutics, Inc. founded?
Swing Therapeutics, Inc. was founded in 2019.
What industry is Swing Therapeutics, Inc. in?
Swing Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Swing Therapeutics, Inc. based?
Swing Therapeutics, Inc. is headquartered in San Francisco, United States.